1Ackerman BH,Ross J,Tofet RW,et al.Effect of decreased renal function on the pharmacokinetics of ceftazidime.[J].Antimierob Agent Chemother,1984,25(6):785-786.
2Norrby SR,Bummn LA,Liderhdm H,et al.Ceftazidime:pharmacokinetics in patients and effects on the renal function[J].J Antimicrob Chemother,1982,10(3):199-206.
3Dalen R,Vree TB,Baars AM,et al.Dosage adjustment for ceftazidime in patients with impaired renal function[J].Eur J Clin Pharmacol,1986,30(5):597-605.
6Hoffler D, Koeppe P, Williams KJ. The pbarmacokinetics of ceftazidime in normal and impaired renal funetion[J].J Antimicrob Chemother, 1983,12:241-245.
7Pasko MT, Beam TR, Spooner JA, et al. Safety and Dharmacokinetics of ceftazidime in patients with chronic hepatic dysfunction[J]. J Antimicrob Chemother, 1985,15: 365-374.
8Nikolaidis P, Tourkantonis A. Effect of hemodialysis on ceftazidime pharmacokinetics[J]. Clin Nephrol, 1985,24: 142-146.
9Ferrara N, Abete P, Giordano M, et al. Neurotoxocity induced by cefepime in a very old hemodialysis patient [J]. Clia Nephrol, 2003,59:388-389.
10Ohkawa M, Nakashima T, Shoda R, et al. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis[J]. Chemotherapy, 1985, 31: 410-416.
